Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cogent Biosciences (COGT)
NASDAQ:COGT
Cogent Biosciences (COGT) Stock Price & Analysis
424 Followers
COGT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.19 - $15.68
Previous Close$9.35
Volume1.51M
Average Volume (3M)704.90K
Market Cap
$799.10M
Enterprise Value$489.06M
Total Cash (Recent Filing)$329.40M
Total Debt (Recent Filing)$19.36M
Price to Earnings (P/E)-4.2
Beta0.64
Next Earnings
Nov 13, 2023EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.20
Shares Outstanding85,465,249
10 Day Avg. Volume573,070
30 Day Avg. Volume704,901
Standard Deviation0.67
R-Squared0.02
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.82
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue248.38
Enterprise Value/Gross Profit186.59
Enterprise Value/Ebitda-4.08
Forecast
1Y Price Target
$23.67Price Target Upside160.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Cogent Biosciences News
Stock Analysis & IdeasAnalysts Say These 2 Stocks Are Their ‘Top Picks’ for the Re...
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
COGT FAQ
What was Cogent Biosciences’s price range in the past 12 months?
Cogent Biosciences lowest stock price was $9.19 and its highest was $15.68 in the past 12 months.
What is Cogent Biosciences’s market cap?
Currently, no data Available
When is Cogent Biosciences’s upcoming earnings report date?
Cogent Biosciences’s upcoming earnings report date is Nov 13, 2023 which is in 26 days.
How were Cogent Biosciences’s earnings last quarter?
Cogent Biosciences released its earnings results on Aug 08, 2023. The company reported -$0.59 earnings per share for the quarter, missing the consensus estimate of -$0.544 by -$0.046.
Is Cogent Biosciences overvalued?
According to Wall Street analysts Cogent Biosciences’s price is currently Undervalued.
Does Cogent Biosciences pay dividends?
Cogent Biosciences does not currently pay dividends.
What is Cogent Biosciences’s EPS estimate?
Cogent Biosciences’s EPS estimate is -$0.5.
How many shares outstanding does Cogent Biosciences have?
Cogent Biosciences has 85,465,250 shares outstanding.
What happened to Cogent Biosciences’s price movement after its last earnings report?
Cogent Biosciences reported an EPS of -$0.59 in its last earnings report, missing expectations of -$0.544. Following the earnings report the stock price went up 7.616%.
Which hedge fund is a major shareholder of Cogent Biosciences?
Among the largest hedge funds holding Cogent Biosciences’s share is RA Capital Management. It holds Cogent Biosciences’s shares valued at 76M.
---
Cogent Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.67 (160.97% Upside)
$23.67 (160.97% Upside)
Blogger Sentiment
Bullish
COGT Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 3.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.68%
12-Months-Change
Fundamentals
Return on Equity
-47.12%
Trailing 12-Months
Asset Growth
7.19%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cogent Biosciences
Unum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer. The firm's technologies include Antibody-Coupled T-cell Receptor, which is a chimeric protein that binds to tumor targeting antibodies. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding COGT
Vanguard Total Stock Market ETF
$24.09M
Vanguard Health Care ETF
$1.81M
Schwab U.S. Broad Market ETF
$378.78K
iShares Russell 3000 ETF
$232.67K
Vanguard Russell 3000 ETF
$53.12K
Up to five ETFs with an Outperform Smart Score that hold COGT. The ETFs are listed according to market value of COGT within the ETF
---